BDNF and Alzheimer disease: ,86 Currently, BDNF administration for AD in clinical trials is ongoing, with a focus on the regulation of BDNF expression and the delivery: precise regulation of BDNF expression is essential, as both overload and insufficiency can cause adverse effects.87